Peter F Billingsley Selected Research

Saline Solution

1/2020

A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter F Billingsley Research Topics

Disease

42	Malaria 03/2022 - 09/2008
32	Infections 03/2022 - 06/2002
11	Bites and Stings (Sting) 01/2020 - 10/2010
6	Parasitemia 02/2022 - 01/2016
3	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2017 - 01/2010
1	Lymphadenopathy 11/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Sickle Cell Trait 01/2018
1	Myalgia 01/2017
1	Headache (Headaches) 01/2017
1	Fever (Fevers) 01/2017
1	Fatigue 01/2017
1	Parasitic Diseases (Parasitic Disease) 03/2013
1	Schistosomiasis (Bilharziasis) 03/2013
1	Vector Borne Diseases 09/2008
1	Dengue (Dengue Fever) 09/2008
1	Starvation 12/2002

Drug/Important Bio-Agent (IBA)

34	VaccinesIBA 02/2022 - 06/2002
24	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 03/2022 - 01/2013
11	Malaria VaccinesIBA 11/2020 - 10/2010
6	Pharmaceutical PreparationsIBA 01/2017 - 01/2013
5	Chloroquine (Aralen)FDA LinkGeneric 01/2021 - 10/2010
3	AntigensIBA 02/2022 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 12/2002
3	Antimalarials (Antimalarial Agents)IBA 01/2017 - 01/2013
2	AntibodiesIBA 02/2022 - 10/2020
1	Ribosomal DNA (rDNA)IBA 03/2022
1	Merozoite Surface Protein 1 (MSA1)IBA 02/2022
1	Pyrimethamine (Daraprim)FDA Link 01/2021
1	18S Ribosomal RNAIBA 01/2021
1	Saline SolutionIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Mefloquine (Lariam)FDA LinkGeneric 01/2017
1	Immune Sera (Antisera)IBA 04/2015
1	Peptides (Polypeptides)IBA 03/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2002

Therapy/Procedure

3	Chemoprevention 01/2021 - 01/2017
3	Intradermal Injections 05/2015 - 01/2013
2	Mass Drug Administration 01/2017 - 12/2015
2	Injections 12/2015 - 12/2015
1	Intravenous Injections 01/2017
1	Intramuscular Injections 01/2014